GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » 5-Year EBITDA Growth Rate

Acro Biomedical Co (Acro Biomedical Co) 5-Year EBITDA Growth Rate : 0.00% (As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co 5-Year EBITDA Growth Rate?

Acro Biomedical Co's EBITDA per Share for the three months ended in Jun. 2023 was $-0.05.

During the past 3 years, the average EBITDA Per Share Growth Rate was -208.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Acro Biomedical Co was -108.00% per year. The lowest was -208.40% per year. And the median was -158.20% per year.


Competitive Comparison of Acro Biomedical Co's 5-Year EBITDA Growth Rate

For the Medical Distribution subindustry, Acro Biomedical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acro Biomedical Co's 5-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Acro Biomedical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's 5-Year EBITDA Growth Rate falls into.



Acro Biomedical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Acro Biomedical Co  (OTCPK:ACBM) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Acro Biomedical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Acro Biomedical Co (Acro Biomedical Co) Business Description

Traded in Other Exchanges
N/A
Address
12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.
Executives
Pao-chi Chu director, 10 percent owner, officer: CEO 2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines